PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019

 

PMV is stepping into a strategic partnership with flanders.bio as of June 1st, 2019.
Through this partnership with flanders.bio, PMV underlines its engagement of enabling Life Science Innovation in particular in Flanders.

“Becoming a strategic partner of flanders.bio is a very obvious choice to reflect the importance for PMV of a flourishing Flemish life sciences ecosystem. Being amongst the most active investors in life sciences in Flanders, we recognize the excellence of innovation and value creation by ventures developing novel products offering solutions for unmet medical needs or sustainable agriculture. In the life sciences sector, access to finance is of utmost importance to turn innovative ideas into commercially valuable product opportunities that have a profound impact on every day’s life. As a finance provider, we feel therefore honored to become a strategic partner to the largest life sciences member-organization consisting of over 350 companies, active throughout the entire value chain, and we intend to actively contribute to further showcasing Flanders as a leading European life sciences hub.” Says Chris De Jonghe, Head of Life Sciences & Care at PMV and board member of flanders.bio since 2016.

 

“We are very pleased with PMV as new strategic partner of flanders.bio. We share a common view that entrepreneurship and innovation is crucial for the future of the Flemish life sciences ecosystem. With this partnership we will further strengthen the range of expertise we are building to support our members from start-up through the different growth stages and beyond. Over the past years, flanders.bio has moved from a pioneering role representing, promoting and connecting biotechnology companies to a more content driven organisation and key player in the life sciences ecosystem. As such our strategic partnerships are also essential in the development of our long-term strategic vision to further strengthen the life sciences ecosystem in Flanders” Adds Pascale Engelen, Co-General Manager at flanders.bio

 

Note

About PMV
PMV is a do and dare company that shapes the economic future of Flanders. PMV finances promising companies from the very start to growth and internationalization, by providing venture capital, loans and guarantees. PMV has a portfolio of about EUR 1.2 billion in assets under management and operates an evergreen venture capital franchise in life sciences. Through this activity, PMV supports highly innovative companies with the potential to generate financial return both for its funds and the region of Flanders. Being a very active investor, PMV helps building businesses by investing in both early- and growth stage companies in all areas of biotech and healthcare, ie therapeutics, diagnostics, agrobiotech, medical devices, digital healthcare and next generation technologies. PMV’s current portfolio contains 32 Life Sciences companies, such as Confo Therapeutics, Biocartis, Agrosavfe, Sequana Medical, Lindacare and Pharmafluidics.


For more information, visit www.pmv.eu

 

About flanders.bio
flanders.bio is a dynamic, member driven organisation with currently more than 350 members from Belgium and abroad. We help our members to create value by organising Networking and Training Activities, supporting Internationalisation, providing Services and building Expertise.
flanders.bio and its members want to be the proud advocates of a reputable global-impact ecosystem in life sciences.
flanders.bio is supported by a number of strategic partners: Flanders Investment & Trade, IQVIA, Janssen Pharmaceutica, KBC Securities, Modis, PwC, QbD, Select, VIB and Flanders Innovation & Entrepreneurship


For more info, please visit www.flanders.bio.

 

 

Interested in a regular update of the Life Sciences and biotech sector in Flanders?